Electromed (ELMD) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Electromed (ELMD) has outperformed Outset Medical (OM) over the past year, losing 11.3% versus a loss of 34.5%. Over five years, ELMD leads with a +99.1% price change compared with -99.6% for OM. Electromed is the larger company by market cap ($187.8 million vs $53.0 million), about 3.5 times the size.
Electromed converts more of its revenue into profit, with a net margin of 15.3% versus -68.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | OM |
|---|---|---|
| Share price | $22.98 | $2.81 |
| Market cap | $187.84M | $53.03M |
| 1-day change | -1.20% | -3.44% |
| YTD return | -21.09% | -24.26% |
| 1-year return | -11.31% | -34.50% |
| 5-year return | +99.13% | -99.61% |
| P/E ratio (TTM) | 16.65 | — |
| Forward P/E | 37.67 | — |
| EPS (TTM) | $1.38 | $-3.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $73.78M | $119.48M |
| Revenue growth (YoY) | +15.28% | +5.09% |
| Net income (latest FY) | $11.30M | $-81.65M |
| Gross margin | 78.54% | 39.13% |
| Operating margin | 18.82% | -55.83% |
| Net margin | 15.32% | -68.34% |
| 52-week high | $47.40 | $6.49 |
| 52-week low | $22.67 | $2.77 |
| Distance from 52-week high | -51.52% | -56.70% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +111.05% | +172.95% |
| Average volume | 83.59K | 140.40K |
| Shares outstanding | 8.17M | 18.87M |
| Employees | 195 | 310 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Electromed is about 3.5 times larger than Outset Medical by market value ($187.84M vs $53.03M).
- ELMD has outperformed OM by 23.2 percentage points over the past year.
- Electromed is more profitable, keeping 15.3 cents of every revenue dollar as net income versus -68.3 cents for Outset Medical.
- Electromed grew revenue faster in its latest fiscal year (+15.28% vs +5.09%).
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
ELMD vs OM FAQ
Which is bigger, Electromed or Outset Medical?
Electromed (ELMD) is larger, with a market capitalization of $187.84M compared with $53.03M for Outset Medical (OM).
Which stock has performed better over the past year, ELMD or OM?
ELMD returned -11.31% over the past 12 months, compared with -34.50% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and Outset Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.